The top DE-miRNA, miR-718, is involved in the regulation of vascular remodeling (Martínez-Micaelo et al., 2017), angiogenesis (Xue et al., 2014), and VEGF signaling (Leng et al., 2014), which are impacted by MetS. The gene discussed is VEGFA; the disease is metabolic syndrome.